These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36048155)

  • 1. Structural bases for the higher adherence to ACE2 conferred by the SARS-CoV-2 spike Q498Y substitution.
    Erausquin E; Glaser F; Fernández-Recio J; López-Sagaseta J
    Acta Crystallogr D Struct Biol; 2022 Sep; 78(Pt 9):1156-1170. PubMed ID: 36048155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ensemble-Based Mutational Profiling and Network Analysis of the SARS-CoV-2 Spike Omicron XBB Lineages for Interactions with the ACE2 Receptor and Antibodies: Cooperation of Binding Hotspots in Mediating Epistatic Couplings Underlies Binding Mechanism and Immune Escape.
    Raisinghani N; Alshahrani M; Gupta G; Verkhivker G
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors.
    Gkekas I; Katsamakas S; Mylonas S; Fotopoulou T; Magoulas GΕ; Tenchiu AC; Dimitriou M; Axenopoulos A; Rossopoulou N; Kostova S; Wanker EE; Katsila T; Papahatjis D; Gorgoulis VG; Koufaki M; Karakasiliotis I; Calogeropoulou T; Daras P; Petrakis S
    J Chem Inf Model; 2024 Nov; 64(22):8562-8585. PubMed ID: 39535926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad Neutralization Capacity of an Engineered Thermostable Three-Helix Angiotensin-Converting Enzyme 2 Polypeptide Targeting the Receptor-Binding Domain of SARS-CoV-2.
    Cavazzini D; Levati E; Germani S; Ta BL; Monica L; Bolchi A; Donofrio G; Garrapa V; Ottonello S; Montanini B
    Int J Mol Sci; 2024 Nov; 25(22):. PubMed ID: 39596383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a druggable site on GRP78 at the GRP78-SARS-CoV-2 interface and virtual screening of compounds to disrupt that interface.
    Lazou M; Hutton JR; Chakravarty A; Joseph-McCarthy D
    J Comput Aided Mol Des; 2024 Jan; 38(1):6. PubMed ID: 38263499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2.
    Wang J; Beyer D; Vaccarin C; He Y; Tanriver M; Benoit R; Deupi X; Mu L; Bode JW; Schibli R; Müller C
    Eur J Nucl Med Mol Imaging; 2024 Dec; 52(1):9-21. PubMed ID: 39066808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical evolution of the receptor-binding domains of SARS-CoVs.
    Upadhyay V; Panja S; Lucas A; Patrick C; Mallela KMG
    Biophys J; 2023 Dec; 122(23):4489-4502. PubMed ID: 37897042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The flavonoid quercetin decreases ACE2 and TMPRSS2 expression but not SARS-CoV-2 infection in cultured human lung cells.
    Houghton MJ; Balland E; Gartner MJ; Thomas BJ; Subbarao K; Williamson G
    Biofactors; 2024; 50(6):1268-1286. PubMed ID: 38886986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding affinity for Omicron B.1.1.529 spike RBD compared to wild type reference.
    Durmaz V; Köchl K; Krassnigg A; Parigger L; Hetmann M; Singh A; Nutz D; Korsunsky A; Kahler U; König C; Chang L; Krebs M; Bassetto R; Pavkov-Keller T; Resch V; Gruber K; Steinkellner G; Gruber CC
    Sci Rep; 2022 Aug; 12(1):14534. PubMed ID: 36008461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free Energy Perturbation Calculations of Mutation Effects on SARS-CoV-2 RBD::ACE2 Binding Affinity.
    Sergeeva AP; Katsamba PS; Liao J; Sampson JM; Bahna F; Mannepalli S; Morano NC; Shapiro L; Friesner RA; Honig B
    J Mol Biol; 2023 Aug; 435(15):168187. PubMed ID: 37355034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitriol prevents SARS-CoV spike-induced inflammation in human trophoblasts through downregulating ACE2 and TMPRSS2 expression.
    Vargas-Castro R; García-Quiroz J; Olmos-Ortiz A; Avila E; Larrea F; Díaz L
    J Steroid Biochem Mol Biol; 2025 Jan; 245():106625. PubMed ID: 39515592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants.
    Bajoria S; Kaur K; Kumru OS; Van Slyke G; Doering J; Novak H; Rodriguez Aponte SA; Dalvie NC; Naranjo CA; Johnston RS; Silverman JM; Kleanthous H; Love JC; Mantis NJ; Joshi SB; Volkin DB
    Hum Vaccin Immunother; 2022 Nov; 18(5):2079346. PubMed ID: 35666264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic characterization of ENPEP, the gene encoding a potential cofactor for SARS-CoV-2 infection.
    Arppo A; Barker H; Parkkila S
    PLoS One; 2024; 19(12):e0307731. PubMed ID: 39661628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Far Posterior Approach for Rib Fracture Fixation: Surgical Technique and Tips.
    Manes TJ; DeGenova DT; Taylor BC; Patel JN
    JBJS Essent Surg Tech; 2024; 14(4):. PubMed ID: 39650795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains.
    Starr TN; Greaney AJ; Stewart CM; Walls AC; Hannon WW; Veesler D; Bloom JD
    PLoS Pathog; 2022 Nov; 18(11):e1010951. PubMed ID: 36399443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic study of the transmission pattern of the SARS-CoV-2 omicron variant.
    An K; Yang X; Luo M; Yan J; Xu P; Zhang H; Li Y; Wu S; Warshel A; Bai C
    Proteins; 2024 Jun; 92(6):705-719. PubMed ID: 38183172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization.
    Gu M; Torres JL; Li Y; Van Ry A; Greenhouse J; Wallace S; Chiang CI; Pessaint L; Jackson AM; Porto M; Kar S; Li Y; Ward AB; Wang Y
    Emerg Microbes Infect; 2021 Dec; 10(1):2016-2029. PubMed ID: 34651563
    [No Abstract]   [Full Text] [Related]  

  • 19. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.